Company Filing History:
Years Active: 2020-2021
Title: Francesca Buttini: Innovator in Pharmaceutical Aerosol Formulations
Introduction
Francesca Buttini is a distinguished inventor based in Parma, Italy, known for her contributions to the field of pharmaceutical formulations. With three patents to her name, she has made significant strides in enhancing the delivery of beta-agonist medications.
Latest Patents
Francesca's latest inventions demonstrate her innovative approach to pharmaceutical science. Her first notable patent involves "Crystalline microparticles of a beta-agonist coated with a fatty acid." This invention pertains to crystalline microparticles featuring a phenylalkylamino beta-adrenergic agonist, which are coated with a C12-C20 fatty acid. These microparticles are particularly useful in preparing pharmaceutical aerosol formulations, either in the form of suspensions in a liquefied propellant gas or as powder formulations.
Her second recent patent, "Carrier particles for dry powder formulations for inhalation," focuses on granules that serve as carrier particles in dry powder formulations for inhalation. This invention is particularly advantageous for administering high-strength dose active ingredients, improving the efficiency and effectiveness of inhalation therapies.
Career Highlights
Francesca Buttini has cultivated a remarkable career at Chiesi Farmaceutici S.p.A., where she has leveraged her expertise in pharmaceutical development. Throughout her tenure, she has dedicated her work to enhancing drug delivery systems and has played a pivotal role in advancing technologies that improve patient outcomes.
Collaborations
Collaboration is key to innovation, and Francesca has worked alongside renowned colleagues, including Francesca Schiaretti and Ruggero Bettini. Together, they contribute to research and development initiatives that push the boundaries of pharmaceutical science.
Conclusion
Francesca Buttini's inventive spirit and dedication to improving pharmaceutical formulations are evident through her patents and collaborations. As she continues her work at Chiesi Farmaceutici S.p.A., she remains a vital contributor to advancements in the field, paving the way for more effective therapies that can transform patient care.